NSE filing, NSE: WANBURY. Summary written from the filing by ALFA Finder's alert engine.
Wanbury Ltd: key numbers
- Share price
- ₹174.16
- Market cap
- ₹609.0 Cr
- Revenue (annual)
- ₹650.3 Cr
- Net profit (annual)
- ₹66.13 Cr
- P/E (TTM)
- 10.9×Sector 46.1×
- Promoter holding
- 42.98%-0.04% QoQ
- FII holding
- 0.71%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Wanbury Ltd
All →Wanbury Board Meeting Date
Wanbury Limited has scheduled its Board Meeting for 4 Nov 2026 to consider unaudited half-year results. No financial figures or material decisions are disclosed in this advance intimation.
Wanbury Other Announcement
Wanbury Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI listing regulations.
Wanbury Business Update
Wanbury Limited received nine "No DMF Deficiency" letters from the USFDA for Metformin HCl. The company also expanded its business in Saudi Arabia and Mexico with an annual revenue potential of Rs 25 Crore.
Wanbury Product Launch
Wanbury Skin Health launched its berrysoft baby product range across multiple Indian states. This marks the company's strategic entry into the paediatric dermatology segment.
Wanbury Business Update
Wanbury filed new Drug Master Files in South Africa, Philippines and Singapore for its APIs. It also added KSM vendors and received EDQM/TGA compliance clearances.
Wanbury Management Change
Wanbury Limited announced the appointment of ABK & Associates as Cost Auditor and the re-appointment of Mohan Kumar Rayana as Executive Director.
Other business update announcements
All →OnEMI Technology Solutions Business Update
OnEMI Technology Solutions (Kissht) disclosed its Key Performance Indicators for the quarter ended 30 September 2026. The KPIs, including those defined in its May 2026 prospectus, are published on the company website.
Hero MotoCorp Business Update
Hero MotoCorp updated its code of practices for fair disclosure of unpublished price-sensitive information, effective 28 October 2026. The revised code governs disclosure, spokespersons and analyst interactions.
Cybele Industries Business Update
Cybele Industries disclosed joint venture discussions with a third party, still at an initial stage. No agreement has been executed and no value is stated.
Dr. Reddy's Laboratories Business Update
Dr Reddy's says USFDA closed its PAI and GMP inspection at Srikakulam FTO-SEZ Process Unit-02 with VAI classification. The outcome is closed with no monetary penalty.
Vascon Engineers Business Update
Vascon Engineers awarded Neobridge Realty LLP a Rs.72 Crore shell and core work contract over 25 months. The contract is excluding GST and is described as ordinary course of business.
- Value
- ₹72.00 Cr
- Execution
- 25 months
Meesho Business Update
Meesho's Q2 FY27 shareholders' letter reports NMV up 23% YoY to ₹12,911 crore. Festive timing moved the Mega Blockbuster Sale into Q3.